KR870010049A - 아릴-치환된 나프티리딘 및 피리도 피라진 유도체, 및 그들의 제조 방법 - Google Patents

아릴-치환된 나프티리딘 및 피리도 피라진 유도체, 및 그들의 제조 방법 Download PDF

Info

Publication number
KR870010049A
KR870010049A KR870003429A KR870003429A KR870010049A KR 870010049 A KR870010049 A KR 870010049A KR 870003429 A KR870003429 A KR 870003429A KR 870003429 A KR870003429 A KR 870003429A KR 870010049 A KR870010049 A KR 870010049A
Authority
KR
South Korea
Prior art keywords
compound
mammal
naphthyridin
cor
alkyl
Prior art date
Application number
KR870003429A
Other languages
English (en)
Korean (ko)
Inventor
존 블리틴 데이비드
슈에 호-제인
아이라 시에겔 마빈
란달 스미스 시드니
Original Assignee
스테이나르 브이. 칸스타드
쉐링 코퍼레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/921,288 external-priority patent/US4882332A/en
Application filed by 스테이나르 브이. 칸스타드, 쉐링 코퍼레이션 filed Critical 스테이나르 브이. 칸스타드
Publication of KR870010049A publication Critical patent/KR870010049A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR870003429A 1986-04-11 1987-04-10 아릴-치환된 나프티리딘 및 피리도 피라진 유도체, 및 그들의 제조 방법 KR870010049A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85106886A 1986-04-11 1986-04-11
US851068 1986-04-11
US921288 1986-10-20
US06/921,288 US4882332A (en) 1986-10-20 1986-10-20 Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives

Publications (1)

Publication Number Publication Date
KR870010049A true KR870010049A (ko) 1987-11-30

Family

ID=27126973

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870003429A KR870010049A (ko) 1986-04-11 1987-04-10 아릴-치환된 나프티리딘 및 피리도 피라진 유도체, 및 그들의 제조 방법

Country Status (16)

Country Link
EP (1) EP0241291B1 (xx)
JP (1) JPH0774215B2 (xx)
KR (1) KR870010049A (xx)
AT (1) ATE90096T1 (xx)
AU (1) AU609389B2 (xx)
CA (1) CA1324381C (xx)
DE (1) DE3786036T2 (xx)
DK (1) DK186487A (xx)
ES (1) ES2054665T3 (xx)
FI (1) FI88033C (xx)
HU (1) HU200768B (xx)
IL (1) IL82150A0 (xx)
NO (1) NO165923C (xx)
NZ (1) NZ219931A (xx)
OA (1) OA08583A (xx)
PT (1) PT84658B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
AU2009333653B2 (en) * 2008-12-17 2015-09-10 Merck Patent Gmbh C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
EP0144996B1 (en) * 1983-12-14 1990-02-28 Schering Corporation Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions
US4596809A (en) * 1985-03-25 1986-06-24 Schering Corporation Substituted 1,8-naphthyridinones, useful as anti-allergic agents
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser

Also Published As

Publication number Publication date
NO165923B (no) 1991-01-21
PT84658B (pt) 1989-11-30
HUT43847A (en) 1987-12-28
NZ219931A (en) 1989-10-27
HU200768B (en) 1990-08-28
DK186487D0 (da) 1987-04-10
NO165923C (no) 1991-05-02
FI88033B (fi) 1992-12-15
DE3786036T2 (de) 1993-09-09
IL82150A0 (en) 1987-10-30
DK186487A (da) 1987-10-12
JPS62270582A (ja) 1987-11-24
JPH0774215B2 (ja) 1995-08-09
PT84658A (en) 1987-05-01
DE3786036D1 (de) 1993-07-08
OA08583A (fr) 1988-09-30
EP0241291A3 (en) 1989-05-31
ATE90096T1 (de) 1993-06-15
EP0241291A2 (en) 1987-10-14
FI88033C (fi) 1993-03-25
EP0241291B1 (en) 1993-06-02
CA1324381C (en) 1993-11-16
AU7135887A (en) 1987-10-15
FI871568A0 (fi) 1987-04-09
ES2054665T3 (es) 1994-08-16
FI871568A (fi) 1987-10-12
NO871507D0 (no) 1987-04-10
AU609389B2 (en) 1991-05-02
NO871507L (no) 1987-10-12

Similar Documents

Publication Publication Date Title
TR200000837A2 (tr) Anti-kanser bileşimleri hazırlamak için işlem ve ara maddeler.
KR910020009A (ko) 비사이클릭 1-아자-사이클로알칸
ES2108375T3 (es) Derivados de oxazolidinadiona, su produccion y utilizacion para reducir los niveles de azucares y lipidos en sangre.
NO153455C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte imidazolderivater.
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ATE10192T1 (de) Substituierte imidazol-derivate, deren herstellung und verwendung.
ATE21246T1 (de) Substituierte imidazol-derivate mit pharmakologischer wirkung sowie ihre herstellung und verwendung.
ATE18196T1 (de) 1,4-acyloxynaphthalenderivate, diese enthaltende kompositionen, verfahren fuer ihre herstellung und zwischenprodukte dafuer.
KR900016167A (ko) 아릴-치환된 로다닌 유도체
KR870010049A (ko) 아릴-치환된 나프티리딘 및 피리도 피라진 유도체, 및 그들의 제조 방법
ES538903A0 (es) Procedimiento para la preparacion de agentes anti-psoriaticos del tipo naftalenico
ATE39920T1 (de) Cyclopentylether, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung.
ATE52249T1 (de) Aminoalkyl-substituierte harnstoffderivate, deren saeureadditionssalze und enantiomere.
KR910004550A (ko) 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환아미노)-2-부티닐-1-카르바메이트 및 티오카르바메이트와 그의 유도체
ATE62663T1 (de) Indan-derivate, verfahren zu ihrer herstellung und die erhaltenen zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
NZ332575A (en) Sulfonamide-substituted benzopyran derivatives, processes for preparation, medicament use and compositions comprising them
PT90302A (pt) Processo para a preparacao de derivados de lactamas hetero-tetraciclicas
ATE51224T1 (de) Chinolon-inotropische mittel.
DE3770713D1 (de) 8-phenylthiotetrahydrochinolin-derivate und ihre salze, ihre herstellung, verwendung als arzneimittel und zusammensetzungen davon.
NZ217488A (en) Naphthalene derivatives and use as anti-psoriatic agents
KR950005802A (ko) 벤조일아세틸렌 유도체
KR930007950A (ko) 항-알레르기 및 항-천식 활성을 갖는 질소함유 테트라사이클 화합물, 그의 제조방법 및 용도
KR930019675A (ko) 트리아졸로피리다진 화합물, 그의 제법 및 용도
KR910015583A (ko) 락탐 유도체
GB1040732A (en) New imidazole derivatives and process for their production

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application